Header Logo

Connection

CHARLES MINARD to Hydrazines

Back to Details
This is a "connection" page, showing publications CHARLES MINARD has written about Hydrazines.
CHARLES MINARD
Connection Strength
0.242
Hydrazines
  1. Phase I Trial of Selinexor in Pediatric Recurrent/Refractory Solid and CNS Tumors (ADVL1414): A Children's Oncology Group Phase I Consortium Trial. Clin Cancer Res. 2025 May 01; 31(9):1587-1595.
    View in: PubMed
    Score: 0.242
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.